Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (851-860 of 962) with videos related to

Pageof 97
Sort By:
Annals of Internal Medicine|September 30, 2024
Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial DataGerard T Portela, Jeffrey L Carson, Sonja A Swanson, et al.
JACC. Cardiovascular Interventions|May 25, 2019
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS RegistryLauren C Joyce, Usman Baber, Bimmer E Claessen, et al.
The New England Journal of Medicine|March 17, 2015
Long-term use of ticagrelor in patients with prior myocardial infarctionMarc P Bonaca, Deepak L Bhatt, Marc Cohen, et al.
Journal of the American Heart Association|December 21, 2018
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54Marc P Bonaca, Stephen D Wiviott, David A Morrow, et al.
The New England Journal of Medicine|March 12, 2013
Effect of platelet inhibition with cangrelor during PCI on ischemic eventsDeepak L Bhatt, Gregg W Stone, Kenneth W Mahaffey, et al.
The Lancet. Diabetes & Endocrinology|February 17, 2025
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trialRahul Aggarwal, Deepak L Bhatt, Michael Szarek, et al.
The American Journal of Cardiology|October 8, 2023
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT TrialUsman Baber, Alessandro Spirito, Samantha Sartori, et al.
JAMA Cardiology|February 25, 2026
Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical TrialEtienne Puymirat, Gilles Soulat, Benoit Lattuca, et al.
Journal of the American College of Cardiology|October 19, 2019
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCIKuniaki Takahashi, Patrick W Serruys, Ply Chichareon, et al.
Circulation|May 24, 2019
Effect of Alirocumab on Mortality After Acute Coronary SyndromesPhilippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, et al.
Pageof 97

Showing results (851-860 of 962) with videos related to

Sort By:
Pageof 97
Annals of Internal Medicine|September 30, 2024
Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial DataGerard T Portela, Jeffrey L Carson, Sonja A Swanson, et al.
JACC. Cardiovascular Interventions|May 25, 2019
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS RegistryLauren C Joyce, Usman Baber, Bimmer E Claessen, et al.
The New England Journal of Medicine|March 17, 2015
Long-term use of ticagrelor in patients with prior myocardial infarctionMarc P Bonaca, Deepak L Bhatt, Marc Cohen, et al.
Journal of the American Heart Association|December 21, 2018
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54Marc P Bonaca, Stephen D Wiviott, David A Morrow, et al.
The New England Journal of Medicine|March 12, 2013
Effect of platelet inhibition with cangrelor during PCI on ischemic eventsDeepak L Bhatt, Gregg W Stone, Kenneth W Mahaffey, et al.
The Lancet. Diabetes & Endocrinology|February 17, 2025
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trialRahul Aggarwal, Deepak L Bhatt, Michael Szarek, et al.
The American Journal of Cardiology|October 8, 2023
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT TrialUsman Baber, Alessandro Spirito, Samantha Sartori, et al.
JAMA Cardiology|February 25, 2026
Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical TrialEtienne Puymirat, Gilles Soulat, Benoit Lattuca, et al.
Journal of the American College of Cardiology|October 19, 2019
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCIKuniaki Takahashi, Patrick W Serruys, Ply Chichareon, et al.
Circulation|May 24, 2019
Effect of Alirocumab on Mortality After Acute Coronary SyndromesPhilippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, et al.
Pageof 97